Tissue penetration of antimicrobials: Difference between revisions
From IDWiki
No edit summary |
No edit summary |
||
| Line 13: | Line 13: | ||
|β-lactamase inhibitors |
|β-lactamase inhibitors |
||
| |
| |
||
| style="text-align:center" | – |
|||
|– |
|||
| |
| |
||
| |
| |
||
| Line 20: | Line 20: | ||
|[[ampicillin]] |
|[[ampicillin]] |
||
| |
| |
||
| style="text-align:center" | + |
|||
| + |
|||
| |
| |
||
| |
| |
||
| style="text-align:center" | – |
|||
|– |
|||
|- |
|- |
||
| rowspan="4" |Cephalosporins |
| rowspan="4" |Cephalosporins |
||
|first-generation cephalosporins |
|first-generation cephalosporins |
||
| |
| |
||
| style="text-align:center" | – |
|||
|– |
|||
| |
| |
||
| |
| |
||
| style="text-align:center" | – |
|||
|– |
|||
|- |
|- |
||
|second-generation cephalosporins |
|second-generation cephalosporins |
||
| |
| |
||
| style="text-align:center" | – |
|||
|– |
|||
| |
| |
||
| |
| |
||
| Line 45: | Line 45: | ||
| |
| |
||
| |
| |
||
| style="text-align:center" | + |
|||
| + |
|||
|- |
|- |
||
|[[ceftazidime]] |
|[[ceftazidime]] |
||
| |
| |
||
| style="text-align:center" | + |
|||
| + |
|||
| |
| |
||
| |
| |
||
| style="text-align:center" | + |
|||
| + |
|||
|- |
|- |
||
| rowspan="2" |Cephamycins |
| rowspan="2" |Cephamycins |
||
|[[cephamycins]] |
|[[cephamycins]] |
||
| |
| |
||
| style="text-align:center" | – |
|||
|– |
|||
| |
| |
||
| |
| |
||
| Line 67: | Line 67: | ||
| |
| |
||
| |
| |
||
| style="text-align:center" | – |
|||
|– |
|||
|- |
|- |
||
|Carbapenems |
|Carbapenems |
||
| Line 75: | Line 75: | ||
| |
| |
||
| |
| |
||
| style="text-align:center" | + |
|||
| + |
|||
|- |
|- |
||
! colspan="7" |Antibiotics: Non-β-Lactams |
! colspan="7" |Antibiotics: Non-β-Lactams |
||
| Line 85: | Line 85: | ||
| |
| |
||
| |
| |
||
| style="text-align:center" | – |
|||
|– |
|||
|- |
|- |
||
|Chloramphenicol |
|Chloramphenicol |
||
| Line 93: | Line 93: | ||
| |
| |
||
| |
| |
||
| style="text-align:center" | + |
|||
| + |
|||
|- |
|- |
||
|Fluoroquinolones |
|Fluoroquinolones |
||
| |
| |
||
| |
| |
||
| style="text-align:center" | –? |
|||
|–? |
|||
| |
| |
||
| style="text-align:center" | + |
|||
| + |
|||
| style="text-align:center" | + |
|||
| + |
|||
|- |
|- |
||
|Lincosamides |
|Lincosamides |
||
|[[clindamycin]] |
|[[clindamycin]] |
||
| |
| |
||
| style="text-align:center" | – |
|||
|– |
|||
| |
| |
||
| |
| |
||
| style="text-align:center" | + |
|||
| + |
|||
|- |
|- |
||
|Macrolides |
|Macrolides |
||
|[[macrolides]] |
|[[macrolides]] |
||
| |
| |
||
| style="text-align:center" | – |
|||
|– |
|||
| |
| |
||
| style="text-align:center" | + |
|||
| + |
|||
| |
| |
||
|- |
|- |
||
|Nitrofurans |
|Nitrofurans |
||
|[[nitrofurantoin]] |
|[[nitrofurantoin]] |
||
| style="text-align:center" | – |
|||
|– |
|||
| style="text-align:center" | – |
|||
|– |
|||
| style="text-align:center" | + |
|||
| + |
|||
| style="text-align:center" | – |
|||
|– |
|||
| style="text-align:center" | – |
|||
|– |
|||
|- |
|- |
||
|Nitroimidazoles |
|Nitroimidazoles |
||
| Line 133: | Line 133: | ||
| |
| |
||
| |
| |
||
| style="text-align:center" | + |
|||
| + |
|||
|- |
|- |
||
|Rifamycins |
|Rifamycins |
||
| Line 140: | Line 140: | ||
| |
| |
||
| |
| |
||
| style="text-align:center" | + |
|||
| + |
|||
| |
| |
||
|- |
|- |
||
| Line 148: | Line 148: | ||
| |
| |
||
| |
| |
||
| style="text-align:center" | – |
|||
|– |
|||
| |
| |
||
|- |
|- |
||
| Line 154: | Line 154: | ||
|[[tetracyclines]] |
|[[tetracyclines]] |
||
| |
| |
||
| style="text-align:center" | – |
|||
|– |
|||
| |
| |
||
| style="text-align:center" | + |
|||
| + |
|||
| |
| |
||
|- |
|- |
||
| Line 164: | Line 164: | ||
| |
| |
||
| |
| |
||
| style="text-align:center" | + |
|||
| + |
|||
|- |
|- |
||
! colspan="7" |Antifungals |
! colspan="7" |Antifungals |
||
| Line 174: | Line 174: | ||
| |
| |
||
| |
| |
||
| style="text-align:center" | + |
|||
| + |
|||
|} |
|} |
||
[[Category:Antimicrobials]] |
[[Category:Antimicrobials]] |
||
Revision as of 16:21, 24 August 2020
| Class | Antimicrobial | Blood | CNS | Urine | Prostate | Necrotic |
|---|---|---|---|---|---|---|
| Antibiotics: β-Lactams | ||||||
| Penicillins | β-lactamase inhibitors | – | ||||
| ampicillin | + | – | ||||
| Cephalosporins | first-generation cephalosporins | – | – | |||
| second-generation cephalosporins | – | |||||
| cefepime | + | |||||
| ceftazidime | + | + | ||||
| Cephamycins | cephamycins | – | ||||
| cefoxitin | – | |||||
| Carbapenems | imipenem | + | ||||
| Antibiotics: Non-β-Lactams | ||||||
| Aminoglycosides | – | |||||
| Chloramphenicol | chloramphenicol | + | ||||
| Fluoroquinolones | –? | + | + | |||
| Lincosamides | clindamycin | – | + | |||
| Macrolides | macrolides | – | + | |||
| Nitrofurans | nitrofurantoin | – | – | + | – | – |
| Nitroimidazoles | metronidazole | + | ||||
| Rifamycins | rifampin | + | ||||
| Sulfonamides | sulfamethoxazole | – | ||||
| Tetracyclines | tetracyclines | – | + | |||
| doxycycline | + | |||||
| Antifungals | ||||||
| Azoles | fluconazole | + | ||||
References
- ^ Cornelia B. Landersdorfer, Jürgen B. Bulitta, Martina Kinzig, Ulrike Holzgrabe, Fritz Sörgel. Penetration of Antibacterials into Bone. Clinical Pharmacokinetics. 2009;48(2):89-124. doi:10.2165/00003088-200948020-00002.
- ^ L. Brockhaus, D. Goldblum, L. Eggenschwiler, S. Zimmerli, C. Marzolini. Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics. Clinical Microbiology and Infection. 2019;25(11):1364-1369. doi:10.1016/j.cmi.2019.01.017.
